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Abstract
The motor neuron disease amyotrophic lateral sclerosis (ALS) typically begins with
localized muscle weakness. Progressive, widespread paralysis often follows over a
few years. Does the disease begin with local changes in a small piece of neural tis-
sue and then spread? Or does neural decay happen independently across diverse
spatial locations? The distinction matters, because local initiation may arise by local
changes in a tissue microenvironment, by somatic mutation, or by various epigenetic
or regulatory fluctuations in a few cells. A local trigger must be coupled with a mech-
anism for spread. By contrast, independent decay across spatial locations cannot
begin by a local change, but must depend on some global predisposition or spatially
distributed change that leads to approximately synchronous decay. This article out-
lines the conceptual frame by which one contrasts local triggers and spread versus
parallel spatially distributed decay. Various neurodegenerative diseases differ in their
mechanistic details, but all can usefully be understood as falling along a continuum of
interacting local and global processes. Cancer provides an example of disease pro-
gression by local triggers and spatial spread, setting a conceptual basis for clarifying
puzzles in neurodegeneration. Heart disease also has crucial interactions between
global processes, such as circulating lipid levels, and local processes in the develop-
ment of atherosclerotic plaques. The distinction between local and global processes
helps to understand these various age-related diseases.
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Introduction
Initial symptoms of motor neuron disease present as lo-
calized muscle weakness. Motor loss often progresses to
widespread paralysis over a few years1.
The onset of this disease poses a puzzle. Does the disease
arise in a localized focus of neural tissue and then spread
from that focal lesion? Or does the decay arise indepen-
dently in diverse spatial locations?
Suppose that disease begins from a localized origin2,3,4,5,6.
Then onset may start by local changes in a tissue microenvi-
ronment, by somatic mutation, or by various epigenetic or
regulatory fluctuations in a few cells. Those local processes
may transform a small piece of tissue into a focal lesion
that can spread disease to other cells. The widespread de-
cay that ultimately follows happens by local transformation
and then spread.
By contrast, suppose that widespread decay originates in-
dependently in each small site across the broad spatial do-
main of diseased tissue. Then localized genetic, epigenetic
and regulatory changes in a single site cannot be the origin
of the disease. Instead, spatially separated positions must
progress independently.
Clues from sporadic versus inherited disease
Consider the pattern of onset and spread in the most com-
mon motor neuron disease, amyotrophic lateral sclerosis
(ALS).
The majority of cases occur sporadically7. Sporadic means
that there is no direct evidence of predisposing inherited
mutations. These apparently random cases typically occur
after age 40, with incidence increasing up to age 75 and
then declining at later ages8.
Inherited mutations predispose individuals to ALS, causing
familial occurrence1. For example, individuals carrying an
inherited mutation in SOD1 or C9orf72 often have greatly
increased risk of disease.
The age of onset in genetically predisposed cases typically
occurs several years earlier than sporadic disease9,10. Ge-
netically predisposed individuals also have much higher in-
cidence than those without genetic predisposition.
The puzzle is whether disease begins with a local change
that triggers global spread or with dispersed decay over a
broad spatial range. The observed shift in age and inci-
dence associated with inherited mutations provides clues.
Interpreting the clues from the age-incidence shift between
familial and sporadic cases requires attention to two as-
pects. First, the puzzle concerns the dynamics of disease
progression. To understand dynamics, we must consider
the time-related aspects of the disease. Second, we must
frame the clues in relation to the alternatives of localized
versus dispersed origin.
Time from onset to full disease
Individuals with certain inherited mutations have a high
probability of developing ALS. However, the age at which
symptoms first appear varies widely, even for carriers of the
same mutation9. In sporadic cases, the age of first onset
also varies widely.
Once initial symptoms arise, most individuals progress to
final widespread paralysis within a few years. What could
explain variable age for the first appearance of localized
symptoms and the subsequent relatively rapid development
of widely dispersed disease?
Localized versus dispersed origin
I mentioned two possible solutions. First, disease may orig-
inate locally in a small piece of tissue and then spread from
that origin. Second, degeneration may happen nearly si-
multaneously and independently across diverse spatial lo-
cations.
The first solution of local origin and spread fits nicely with
the observed pattern of variable age of onset and rapid sub-
sequent progression.
However, the second solution of parallel distributed decay
could be true. For example, each individual might be prone
to a particular timing of decay across the broad neural land-
scape. Approximate synchrony may arise because of the
common genetic background or environmental exposures
shared by all locations.
For example, a global change in a widely circulating fac-
tor may initiate simultaneous decay across spatial locations.
That global process shifts the locus of causality to the origin
of the widely circulating trigger and to the susceptibility of
the distributed sites across the neural landscape.
Trigger versus spread
Inherited cases have an earlier age of onset than sporadic
cases. That fact refines the alternative solutions of local
versus dispersed origin8,9,10.
In the local origin solution, a shared mutation across all
locations may increase the rate at which the first localized
origin arises. An origin may require several local changes
before it can act as a trigger to initiate spatial spread. If all
locations share a mutation that moves progression ahead,
then the first trigger will happen at an earlier age.
Alternatively, the shared mutation across all locations may
reduce the threshold for spread. A lower threshold may
induce spread in response to a weaker local trigger.
Seed and soil
A reduced threshold for spread suggests a variant of the
dispersed origin solution. A reduced global threshold ex-
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presses distributed decay, but one that still requires an ad-
ditional local origin trigger.
The interaction between local origin and dispersed decay
echoes an old idea from cancer research about seed and
soil11. In that theory, the metastatic spread of cancer re-
quires both a transformed cell that can act as a seed and a
transformed tissue that can act as a soil in which the seed
may grow.
Candidate mechanisms
Alternative explanations focus attention on different mech-
anisms of disease.
Local triggers may arise from various processes: local-
ized environmental insults, tissue microenvironment fluc-
tuations such as infection or inflammation, local vascular
changes, local hypoxia, and local changes in other kinds
of environmental factors. Changes within one or few cells
also initiate local changes: somatic mutation, epigenetic
changes, fluctuations in regulatory state, phenotypic re-
sponses to altered environments, and so on.
Spread may follow from intercellular transfer of RNA or
cytoplasmic components, transmissible misfolding of pro-
teins, diffusible signals, attraction of inflammatory re-
sponses, and so on.
Dispersed origin may arise from wider environmental
changes, including extrinsic insults, inflammation, broad
vascular changes, and so on.
Dispersed origin seems less likely to follow from localized
somatic mutation, random epigenetic changes in cells, or
random fluctuations in cellular regulatory states. This limi-
tation and the absence of important mechanisms of spread
provide the clearest distinction between local versus dis-
persed origin.
Much research focuses on these kinds of alternative mecha-
nisms. However, mechanistic studies often do not explicitly
frame analysis of cause in terms of the variety of potential
mechanisms for local triggers and spread versus the variety
of potential mechanisms for dispersed origin. My only pur-
pose here is to clarify the relation between different mech-
anisms and the broader framework in which we must un-
derstand the puzzles of disease onset and progression.
In the study of mechanism, one must also distinguish rate of
onset versus physiological function12. An inherited muta-
tion may increase the rate at which disease-causing changes
arise in physiological function, but the inherited mutation
itself may have no direct physiological role in disease.
For example, inherited defects in modulators of protein
folding or in clearance of misfolded proteins may raise the
rate at which misfolded proteins act as local triggers of
global spread. Similarly, an inherited increase in somatic
mutation may raise the rate at which local triggers arise.
Alternatively, an inherited mutation may directly initiate a
disease-causing change in a physiological function. For ex-
ample, a mutation in a protein coding gene may increase
the tendency for misfolding of that particular protein. The
increased tendency for misfolding may act as a local trigger
or may lower the global threshold in response to external
triggers.
Neurodegenerative diseases
I have used ALS to illustrate the puzzle of local versus dis-
persed origin of disease. Similar puzzles arise in Parkinson’s
disease, Alzheimer’s disease and other neurodegenerative
diseases.
Within each disease, there will likely be different mecha-
nisms of origin and timing of spread. Between diseases,
there will also likely be different aspects of origin and
spread. The similarities and differences help to understand
broader aspects of disease.
Cancer
At first glance, cancer and neurodegenerative disease seem
very different. Cancer arises at a localized site. One thinks
about the origin of cancer in terms of the local changes in
a few cells and the surrounding tissue microenvironment.
Global factors such as immune system status or hormone
levels may play a role, but they do so to the extent that
they influence local changes at the site of cancer origin.
Progression of cancer depends on the factors that promote
spread. The interactions between local triggers and global
spread dominate all aspects of cancer research. The study
of prevention, early detection, treatment, and basic under-
standing depends on the local-global interaction.
By contrast, most studies of neurodegeneration are vague
about the origin and spread of disease. If a neurodegenera-
tive disease does arise locally and then spread, then such a
disease shares with cancer its general causal structure and
dynamics.
Recently, several studies of neurodegeneration have fo-
cused on the spread of misfolded proteins in a prion-like
manner5,6. However, those studies remain vague about
the variety of mechanisms that influence local triggers and
about the broader conceptual framing of interactions be-
tween local and global processes.
Certainly, different neurogenerative syndromes vary in
their causal structure, and various aspects of cancer and
neurodegeneration differ in significant ways. It would be
useful to understand explicitly the broad conceptual sim-
ilarities and differences between the diseases. It would
also be useful to understand the broader ways in which we
can analyze the dynamics of interactions between local and
global processes.
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Heart disease
Heart disease typically arises from an interaction of local
and global processes. Initially, global factors such as lipid
levels set the preconditions for localized plaque formation
in the inner lining of artery walls.
Although widespread conditions for plaque formation may
occur, severe disease often requires a series of local changes
at individual plaque sites13. For example, the early stages of
local site progression typically include recruitment of leuko-
cytes that mature into macrophages, which take up lipid.
Changes in the local tissue microenvironment associate
with proliferation of nearby muscle cells and tumor-like
expansion and physiological transformation. An advanced
plaque may rupture, attracting platelets and wound healing
processes that make a clot. The clot may block local blood
flow or break off to block flow at a distant site.
Once again, a strong interaction between local and global
processes drives disease progression. The particular timing
of the local and global factors differs between heart dis-
ease, cancer and neurodegeneration. However, these age-
related diseases share a common frame of interacting local
and global processes that cause disease onset14,15.
Conclusions
Why does emphasis on interacting local and global pro-
cesses matter? Consider the basic understanding of disease
onset in neurodegeneration.
If a local trigger starts the process, then a localized mi-
croenvironmental change or a local somatic mutation can
be the event that initiates disease2,3,4. By contrast, if a
global change initiates disease, then we must look for a fac-
tor that can circulate or diffuse widely and that can alter
conditions over dispersed spatial sites.
With either initial local or global changes to start disease,
progression typically depends on further interactions be-
tween subsequent local and global processes. For example,
a high global level of certain lipids may be an important
trigger of heart disease. Subsequent progression depends
on local changes at plaque sites.
Much biological research hunts for the causes of disease.
With better basic understanding of cause, one may improve
prevention, detection and treatment. However, the notion
of cause is always slippery and requires careful thought to
frame properly.
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